Author

Linda Huang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Olivier ElementoiD· 2 shared Andrea SboneriD· 1 shared David Pisapia· 1 shared Giuseppe Galletti· 1 shared Hamid Zia· 1 shared Hanna RennertiD· 1 shared Helen Fernandes· 1 shared Joshua E. Allen· 1 shared

Activity by Year

2016-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Olivier ElementoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A New Big-Data Paradigm For Target Identification And Drug Discovery

Neel S. Madhukar, Prashant K. Khade, Linda Huang, Kaitlyn Gayvert, Giuseppe Galletti, Martin Stogniew, Joshua E. Allen, Paraskevi Giannakakou, Olivier Elemento

This paper introduces BANDIT, a Bayesian machine-learning framework for drug target identification, achieving 90% accuracy in predicting targets for 2000 small molecules and validating novel microtubule inhibitors and the target of ONC201.

bioRxiv · May 7, 2017 · PreprintPharmacology & Toxicology

The Precision Medicine Knowledge Base: an online application for collaborative editing, maintenance and sharing of structured clinical-grade cancer mutations interpretations

Linda Huang, Helen Fernandes, Hamid Zia, Peyman Tavassoli, Hanna Rennert, David Pisapia, Marcin Imielinski, Andrea Sboner, Mark A Rubin, Michael Kluk, Olivier Elemento

The paper introduces PMKB, a platform for collaborative editing and sharing of clinical-grade cancer mutation interpretations, and reports its usage in genomic testing.

Journal of the American Medical Informatics Association · Oct 27, 2016Peer-reviewedGenomics